Browser Not Supported.

IE users: please get the latest browser version at Microsoft Internet Explorer Home Page

if yot already have the latest browser version please verify that your browser settings is not in compatibility mode

Browser: unknown
Version: 0

EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content

Derivation and purification of endothelial precursor cells following TGF-beta inhibition

This protocol describes the use of SB431542, a TGF-beta inhibitor molecule, for differentiation and robust expansion of hESCs into endothelial cells. In addition, it contains a purification step by FACS or MACS. The authors used an endothelial cell–specific VE-cadherin promoter driving green fluorescent protein (GFP) (hVPr-GFP) to generate transgenic hESC cells. These transgenic cells were further used to screen for factors that promote vascular commitment.

20-30 days
See additional Protocols for: Endothelium
Derivation and purification of endothelial precursor cells following TGF-beta inhibition